Teva Pharmaceutical Industries (NYSE:TEVA) Hits New 1-Year High at $13.50 - American Banking and Market News
Teva Contemplates Selling $2 Billion Active Ingredients Division | CHEManager
Teva Pharmaceuticals | PPT
Jefferies raises Teva to "Buy" - Globes
Teva looks to sell generics in China through joint venture with Guangzhou Pharma: Bloomberg | Fierce Pharma
Teva Pharmaceutical To Rally Around 58%? Here Are 10 Top Analyst Forecasts For Monday | Markets Insider
Teva Pharmacueticals is giving investors several reasons to buy
Teva Pharmaceuticals - Wikipedia
Teva Plummets on Downgrade Following $85M Opioid Settlement - TheStreet
Teva Pharmaceutical Industries Ltd (TEVA) Stock: How Does it Score on Fundamental Metrics?
Teva Pharmaceuticals To Buy Gecko Health Innovations
Teva to Buy Generics Distributor Anda From Allergan for $500 Million - WSJ
Should You Buy Teva Pharmaceutical Industries Ltd (TEVA) Stock Monday Morning?
Tel Aviv stock indices fall, Teva Pharmaceuticals hits annual high By Investing.com
Teva in Talks to Buy Allergan's Generic-Drug Unit - WSJ
Teva Pharmaceuticals Just Made a Big Announcement, but Is It a Buy? | The Motley Fool
$300 million Teva bet: Will Norway's wealth fund and ION regret investing in the phar | Ctech
Teva Pharmaceutical Industries (TEVA) Stock Price, News & Analysis
Teva Posts 2021 Earnings and Puts Opioid Litigation in Rearview Mirror | BioSpace
What does Teva's growth strategy look like?
Teva Pharmaceutical meets forecasts, but 2023 outlook disappoints | Reuters
Buy, Sell or Hold: Teva Pharmaceutical (TEVA-N) — Stock Predictions at Stockchase
Suffering from missteps, drugmaker Teva struggles to heal own ills | The Times of Israel
Teva Pharmaceuticals has acquired success with Actavis Generics | World Finance
Teva Pharmaceuticals Agrees To $85 Million Settlement With Oklahoma In Opioid Case | Colorado Public Radio
